4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one
Analytical Control
- Product Code: 157034
CAS:
2310316-95-9
| Molecular Weight: | 391.87 g./mol | Molecular Formula: | C₁₈H₁₈ClN₃O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Investigated for its role in improving drug efficacy and selectivity in oncology drug development. Also employed in structure-activity relationship (SAR) studies to optimize bioavailability and binding affinity in novel therapeutic agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | £4,357.65 |
+
-
|
4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Investigated for its role in improving drug efficacy and selectivity in oncology drug development. Also employed in structure-activity relationship (SAR) studies to optimize bioavailability and binding affinity in novel therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :